Llwytho...
Efficacy of Evolocumab in Monogenic vs Polygenic Hypercholesterolemia
BACKGROUND: Inhibitors of proprotein convertase subtilisin kexin 9 are indicated in Canada for treatment of patients with familial hypercholesterolemia (FH). Classically, FH is considered to be a monogenic condition caused by rare pathogenic mutations; however, some patients have hypercholesterolemi...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | CJC Open |
|---|---|
| Prif Awduron: | , , , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
Elsevier
2019
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7063626/ https://ncbi.nlm.nih.gov/pubmed/32159093 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.cjco.2019.02.005 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|